In direct alignment with our results, previous studies have shown that overexpression of SPA17 leads to increased chemoresistance in ovarian cancer cell, while knockdown of SPA17 increased chemosensitivity.19, 20. The gene discussed is SPA17; the disease is ovarian carcinoma.